. . . . . . . "[In myeloid malignancies, CD54 is preferentially expressed by 'stem cell-derived' malignancies, being detectable on blast cells from almost all patients affected by chronic myelogenous leukemia in blast phase or myelodysplastic syndromes and by only 34% of patients with de novo acute myeloid leukemia (AML).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en . . . . . "2017-02-19"^^ . . "Gene-disease associations inferred from text-mining the literature."@en . "DisGeNET evidence - LITERATURE"@en . "2017-10-17T13:13:33+02:00"^^ . . . . . . . . . . . "v5.0.0.0" . "v5.0.0" .